Evidence map›Paper›PMID 32451204›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2020

Global assessment of the integrated stress response in CF patient-derived airway and intestinal tissues.

Giovana B Bampi, Robert Rauscher, Sebastian Kirchner, Kathryn E Oliver, Marcel J C Bijvelds, Leonardo A Santos, Johannes Wagner, Raymond A Frizzell, Hugo R de Jonge, Eric J Sorscher and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Giovana B BampiBiochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany.
Robert RauscherBiochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany.
Sebastian KirchnerBiochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany; University of Potsdam, Potsdam, Germany.
Kathryn E OliverEmory University School of Medicine, Atlanta, GA, USA; Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Marcel J C BijveldsGastroenterology and Hepatology Erasmus MC University Medical Center, Rotterdam, USA.
Leonardo A SantosBiochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany.
Johannes WagnerBiochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany.
Raymond A FrizzellPediatrics and Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Hugo R de JongeGastroenterology and Hepatology Erasmus MC University Medical Center, Rotterdam, USA.
Eric J SorscherEmory University School of Medicine, Atlanta, GA, USA; Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Zoya IgnatovaBiochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany. Electronic address: zoya.ignatova@uni-hamburg.de.
Universität Hamburg · DEEmory University · USUniversity Medical Center · USUniversity of Pittsburgh · US

Funding

Co-chaperone Actions in CFTR BiogenesisR01DK068196 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GOETZMAN, ERIC S · 2004 to 2024
$5.8M
Ribosomal perturbation as a mechanism to prevent misfolding of CFTRR01HL136414 · NHLBI · EMORY UNIVERSITY · PI HARTMAN, JOHN L, SORSCHER, ERIC J · 2018 to 2025
$4.5M
Modulation of ribosome velocity as a means to rescue refractory CF-causing variantsK99HL151965 · NHLBI · EMORY UNIVERSITY · PI OLIVER, KATHRYN E · 2020 to 2021
$211k
NHLBI NIH HHS K99 HL151965NHLBI NIH HHS R01 HL136414NIDDK NIH HHS R01 DK068196
6 · The paper itself

Abstract

backgroundChronic inflammation is a hallmark among patients with cystic fibrosis (CF). We explored whether mutation-induced (F508del) misfolding of the cystic fibrosis transmembrane conductance regulator (CFTR), and/or secondary colonization with opportunistic pathogens, activate tissue remodeling and innate immune response drivers.

methodsUsing RNA-seq to interrogate global gene expression profiles, we analyzed stress response signaling cascades in primary human bronchial epithelia (HBE) and intestinal organoids.

resultsPrimary HBE acquired from CF patients with advanced disease and prolonged exposure to pathogenic microorganisms display a clear molecular signature of activated tissue remodeling pathways, unfolded protein response (UPR), and chronic inflammation. Furthermore, CFTR misfolding induces inflammatory signaling cascades in F508del patient-derived organoids from both the distal small intestine and colon.

conclusionDespite the small patient cohort size, this proof-of-principle study supports the use of RNA-seq as a means to both identify CF-specific signaling profiles in various tissues and evaluate disease heterogeneity. Our global transcriptomic data is a useful resource for the CF research community for analyzing other gene expression sets influencing CF disease signature but also transcriptionally contributing to CF heterogeneity.

Indexed as

Gene Expression ProfilingImmunity, InnateAdultBronchiCells, CulturedCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorEndoplasmic Reticulum StressEpithelial CellsFemaleHumansInflammationMiddle AgedOrganoidsProof of Concept StudySignal TransductionCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorCystic fibrosisER stressF508del-CFTRInflammationRNA-seqTissue remodelingUnfolded protein response (UPR)

Identifiers

PMID32451204
PMCPMC7932027
OpenAlexW3027957750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.